Latest news & insights
Boyds joins Texas Healthcare and Bioscience Institute (THBI) as proud member
Boyds is delighted to have been named as a finalist in the Business Support category of the BioNow Awards 2023.
Boyds collaborates with BioPharma Connections
Boyds partners with BioPharma Connections in the company’s latest move to continue its growth in the U.S.
Double win for Boyds at TOPRA Awards 2023
The TOPRA Awards 2023 saw the Boyds team take home two awards, with our regulatory affairs team crowned winners of the Futures Award and our
Boyds grows regulatory affairs team with new hire
We are delighted to announce the appointment of Monica Pianella as Associate Director of Regulatory Affairs. With over seven years’ experience in advanced therapies, Monica
Boyds launches ‘Conversations in Drug Development’ podcast
Boyds has announced the launch of a brand-new podcast series that aims to keep the scientific and clinical community abreast of the latest advancements in cell and gene therapy and drug development.
Chris Moore discusses key considerations for US biotechs setting up gene therapy studies in Europe
In the viewpoint article: ‘Key considerations for US biotechs setting up gene therapy studies in the UK and Europe’, Chris highlights some of the important things organisations must consider before initiating their study.
The UK Innovative Devices Access Pathway (IDAP) pilot scheme now open for application
The UK has launched The Innovative Devices Access Pathway (IDAP) pilot, a new pathway to support the rapid development of innovative technologies.
Experts at Boyds share ten top tips for starting an early phase clinical trial
The clinical operations and medical affairs experts at Boyds have shared their ten top tips for how to start and promote the success of early phase clinical trials.
